Optimization Of Cancer Treatment Through Overcoming Drug Resistance.

Elshimali, Yahya I; Wu, Yong; Khaddour, Hussein; Wu, Yanyuan; Gradinaru, Daniela; Sukhija, Hema; Chung, Seyung S; Vadgama, Jaydutt V

Elshimali, Yahya I; Wu, Yong; Khaddour, Hussein; Wu, Yanyuan; Gradinaru, Daniela; Sukhija, Hema; Chung, Seyung S; Vadgama, Jaydutt V.

Afiliación

Elshimali YI; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, USA.
Wu Y; David Geffen School of Medicine at UCLA, UCLA's Jonsson Comprehensive Cancer Center, USA.
Khaddour H; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, USA.
Wu Y; David Geffen School of Medicine at UCLA, UCLA's Jonsson Comprehensive Cancer Center, USA.
Gradinaru D; Faculty of Pharmacy, Mazzeh (17th April Street), Damascus University, Damascus, Syria.
Sukhija H; Carol Davila - University of Medicine and Pharmacy, Faculty of Pharmacy, Department of Biochemistry, Romania.
Chung SS; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, USA.
Vadgama JV; David Geffen School of Medicine at UCLA, UCLA's Jonsson Comprehensive Cancer Center, USA.

J Cancer Res Oncobiol ; 1(2)2018.

Article en En | MEDLINE | ID: mdl-29932172

Palabras clave

Drug resistance; Malignancies; Molecular base; Optimal treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Cancer Res Oncobiol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos